Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / TMDI - Titan Medical falls 19% as it needs more time for application for Enos surgical system

TMDI - Titan Medical falls 19% as it needs more time for application for Enos surgical system

Titan Medical Inc.
Titan Medical (TMDI -19.3%) says more time and work is necessary to prepare for an Investigational Device Exemption ("IDE") human clinical study for its Enos robotic single access surgical system. The company now plans The company plans to file an IDE application in Q1 2023 and receiving a response in 1H 2023. If the IDE is approved, Titan says the study will be completed for submittal of a De Novo application in 2024. If all goes according to plans, the company says it could launch Enos in early 2025. Titan ended Q3 2021 with cash of $44.7M.

For further details see:

Titan Medical falls 19% as it needs more time for application for Enos surgical system
Stock Information
Company Name: Titan Medical Inc.
Stock Symbol: TMDI
Market: NASDAQ
Website: titanmedicalinc.com
Menu
TMDI TMDI Quote TMDI Short TMDI News TMDI Articles TMDI Message Board
Get TMDI Alerts

News, Short Squeeze, Breakout and More Instantly...